The Risk of SARS-CoV-2 in Immunosuppressed IBD Patients

This is a rapid review of the risk of infection with SARS-CoV-2, the risk of symptomatic cases of COVID-19, and the severity of these cases in IBD patients. Guidance on how to manage IBD patients at risk for infection, and IBD patients after infection is provided. The prevention of infection in both...

Descripción completa

Detalles Bibliográficos
Autores principales: Higgins, Peter D R, Ng, Siew, Danese, Silvio, Rao, Krishna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Hot Topic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7184434/
https://www.ncbi.nlm.nih.gov/pubmed/32377636
http://dx.doi.org/10.1093/crocol/otaa026
Descripción
Sumario:This is a rapid review of the risk of infection with SARS-CoV-2, the risk of symptomatic cases of COVID-19, and the severity of these cases in IBD patients. Guidance on how to manage IBD patients at risk for infection, and IBD patients after infection is provided. The prevention of infection in both patients and health care providers by reducing elective visits and procedures, utilizing telemedicine, and social isolation is also emphasized to maintain health care services for IBD patients during a growing pandemic.

Ejemplares similares